EUVIMEDEUVIMED entdecken
Crossref

A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis

Harold J Manley, Gideon Aweh, Jill Frament iD, Vladimir Ladik, Eduardo K Lacson

Nephrology Dialysis Transplantation · 13.02.2023 · 38 (2) · 447-454

DOI: 10.1093/ndt/gfac039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 12.02.2022. Verfasst von Harold J Manley und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dialysis Clinic Inc, Nashville, TN, USA. Hauptthemen laut MEDLINE: Hepatitis B Vaccines, Hepatitis B. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vaccination against hepatitis B virus (HBV) is recommended for dialysis patients. Two reports comparing seroprotection (SP) rates following HepB and HepB-CpG in vaccine-naïve patients with chronic kidney disease enrolled few dialysis patients (n = 122 combined). SP rates in a subset of dialysis patients were not reported or not powered to detect statistically significant differences. SP rates in those requiring additional vaccine series or booster doses are not known.

Methods

A retrospective cohort analysis including dialysis patients completing HepB or HepB-CpG vaccination between January 2019 and December 2020. Vaccine-naïve patients received a series of HepB or HepB-CpG (Series 1). A repeat series was given to nonresponders (Series 2). A booster regimen consists of one dose of either vaccine. Primary outcome was achieving SP (anti-HBs >10 mIU/mL) at least 60 days after the last HBV vaccine dose for Series 1 and Series 2, and achieving SP at least 3 weeks post-booster.

Results

For Series 1 (n = 3509), SP after HepB vaccination was significantly higher (62.9% versus 50.1% for HepB-CpG; P < 0.0001). Series 2 (n = 1040) and booster (n = 2028) SP rates were similar between vaccines. Patients that received up to four HepB-CpG doses had higher SP rates compared with four doses of HepB (82.0% versus 62.9%, respectively; P < 0.0001).

Conclusions

SP rates in hepatitis B vaccine-naïve dialysis patients administered a recommended four doses of HepB were higher than those recommended two doses of HepB-CpG. SP rates were higher and achieved sooner if HepB-CpG was utilized initially and, if needed, for Series 2. Optimal HepB-CpG dosing deserves further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B VaccinesHepatitis BHumansRetrospective StudiesRenal DialysisHepatitis B Surface AntigensHepatitis B AntibodiesPhenylbutyrates

Stichwörter der Autor:innen

HepB (Engerix)HepB-CpG (Heplisav B)dialysishepatitis B vaccinationseroprotection

Substanzen

Hepatitis B VaccinesHepatitis B Surface AntigensHepatitis B AntibodiesEngerix-Bgamma-hydroxy-gamma-ethyl-gamma-phenylbutyramidePhenylbutyrates

Autor:innen und Institutionen

  • Dialysis Clinic Inc, Nashville, TN, USA.
  • Tufts Medical Center, Boston, MA, USA.

ORCID-Profile: Jill Frament

Zitieren

APA

Manley, H. J., Aweh, G., Frament, J., Ladik, V., & Lacson, E. K. (2023). A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis. Nephrology Dialysis Transplantation, 38(2), 447-454. https://doi.org/10.1093/ndt/gfac039

Vancouver

Manley HJ, Aweh G, Frament J, Ladik V, Lacson EK. A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis. Nephrology Dialysis Transplantation. 2023;38(2):447-454. doi:10.1093/ndt/gfac039

BibTeX
@article{Manley2023,
  author = {Manley, Harold J and Aweh, Gideon and Frament, Jill and Ladik, Vladimir and Lacson, Eduardo K},
  title = {A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {2},
  pages = {447--454},
  doi = {10.1093/ndt/gfac039}
}
Kostenlos starten →